Adalank

What Is Adalank?

Adalank is described by vendors as a Selank-related peptide modified with an adamantane group, a rigid carbon-based structure sometimes added to drug molecules to improve stability or membrane permeability. It follows the same modification pattern as Adamax, which applies the same adamantane change to Semax, and is sold specifically as a nasal spray.

Selank itself has a genuine, decades-long research and clinical history in Russia, primarily for its anxiolytic, or anxiety-reducing, effects. Adalank's adamantane modification does not appear in any dedicated published research. Claims about improved stability or absorption are general chemistry principles applied by analogy rather than findings demonstrated directly for this compound.

What Research Actually Supports Adalank?

• Selank's Original Research Base

  The clinical evidence behind Selank, the parent compound Adalank is modified from, includes a Russian clinical study comparing it with a standard anxiolytic medication in patients with generalized anxiety disorder and neurasthenia.^[1]

• Selank and Its Proposed Mechanism

  Separate mechanistic research found Selank inhibits enzymes that break down the body's own enkephalin signaling molecules, alongside effects on GABA and other neurotransmitter systems, providing the proposed biological basis for its anxiolytic research.^[2]

• What's Missing: Adalank-Specific Data

  No dedicated clinical or mechanistic studies on Adalank itself were identified in a search of the published literature. The evidence gap should shape how claims about the modified compound are weighed.

How Adalank Is Marketed as Working

• Building on Selank's Established Mechanism

  Research points to Selank slowing enkephalin breakdown and influencing GABA, serotonin, and dopamine systems, the proposed biological basis for Adalank as well since it shares Selank's core sequence.^[2]

• An Unverified Modification

  The adamantane group is marketed as improving stability and nasal absorption, a plausible chemistry principle in general, but one that has not been directly tested for this specific modification of Selank in published research.

Reconstitution and Handling

Adalank is sold as a nasal spray, pre-formulated for intranasal administration rather than requiring reconstitution from a lyophilized powder. Products should be stored according to the specific formulation's labeling, generally refrigerated and protected from light.

Key Takeaways

Adalank is a vendor-marketed modification of Selank without its own dedicated research base. The evidence that does exist, Selank's genuine anxiolytic research, applies to the parent compound rather than the adamantane modification specifically. Treat absorption or stability claims specific to Adalank as unverified extrapolation.

Frequently Asked Questions

Sources and Research

1. Zozulya AA, Neznamov GG, Siuniakov TS, et al. Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia. Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(4):38-48.
2. Zozulya AA, Kost NV, Sokolov OY, et al. The Inhibitory Effect of Selank on Enkephalin-Degrading Enzymes as a Possible Mechanism of Its Anxiolytic Activity. Bull Exp Biol Med. 2001;131(4):315-317.